Lv5
1560 积分 2023-07-20 加入
Nonpeptide αvβ3 Antagonists. 8. In Vitro and in Vivo Evaluation of a Potent αvβ3 Antagonist for the Prevention and Treatment of Osteoporosis
1天前
已完结
Effect of L-000845704, an αVβ3 Integrin Antagonist, on Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporotic Women
1天前
已完结
Discovery of (S)-3-(3-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-4-((R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic αvβ6 Integrin Inhibitor for the Inhaled Treatment of Idiopathic Pulmonary Fibrosis
2天前
已完结
Core Modifications of GSK3335103 toward Orally Bioavailable αvβ6 Inhibitors with Improved Synthetic Tractability
2天前
已完结
Peptidylpropyl isomerase B (PPIB): a suitable reference gene for mRNA quantification in peripheral whole blood
23天前
已完结
Colloidal Stability Assessment of a Model Antibody Oligonucleotide Conjugate
1个月前
已完结
Progress in precision drug delivery systems for neurodegenerative diseases with muscle atrophy
1个月前
已完结
Cardiac and skeletal muscle delivery of biotherapeutics with a blood vessel epicardial substance-targeting peptide
1个月前
已完结
Skeletal-muscle-targeted non-viral delivery of full-length DMD mRNA for Duchenne muscular dystrophy
1个月前
已完结
Myotonic dystrophy type 1: clinical diversity, molecular insights and therapeutic perspectives
1个月前
已完结
皖公网安备34019202002308
